US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AdvisorShares Psychedelics ETF

24.77

+0.06820.28%

Post-market: 24.820.0518+0.21%19:30 EDT

Volume:23.89K

Turnover:594.14K

Market Cap:55.60M

PE:- -

High:25.07

Open:25.01

Low:24.73

Close:24.70

52wk High:27.02

52wk Low:15.63

Shares:2.24M

Float Shares:2.24M

Volume Ratio:0.61

T/O Rate:1.06%

Dividend:1.70

Dividend Rate:6.88%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Compass Pathways PLC Expected to Post a Loss of 40 Cents a Share - Earnings Preview

Compass Pathways Initiated at Equal-Weight by Wells Fargo

Wells Fargo Initiates COMPASS Pathways at Equalweight

MT Newswires Live

Compass Pathways initiated with an Equal Weight at Wells Fargo

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Celldex (CLDX)

Bristol-Myers Squibb Advances New Lung Cancer Combo Into Phase 2: What Investors Should Watch

Takeda’s Elritercept Trial Targets Anemia in Myelofibrosis, Raising Long-Term Upside for TAK

Jazz Pharmaceuticals Advances Phase 3 Cannabidiol Trial in Severe Childhood Epilepsy

Organon to present results from analysis of Phase 3 trials of VTAMA cream

Radiopharm outlines capital raising plans and risk warnings for oncology radiopharma platform

Lightning Minerals shareholders back all capital raising resolutions

Kringle Pharma Launches Additional Phase 3 Trial of Oremepermin Alfa in Acute Spinal Cord Injury

X2M Connect Plans Major Share and Option Issue on ASX

Dalaroo board backs A$1.75m raising to drive gold and rare earths push

Verastem doses first patient in TARGET-D 202 Phase 2 trial

Arrowhead Pharmaceuticals (ARWR) Stock Soars on Strong Phase 3 Trial Results

NRX Pharmaceuticals - on July 21, Nrxd Selected by Darpa for Negotiation of Potential Sparc-tms Clinical Trial Award - SEC Filing

THOMSON REUTERS

Right Resources secures ASX waiver to advance shareholder-backed capital raising

Codeifai Plans Major ASX Placement of Shares and Options

Aguia Resources Raises $3 Million to Advance Phosphate and Gold Projects

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/PSIL/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PSIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","market":"US","secType":"STK","nameCN":"AdvisorShares Psychedelics ETF","latestPrice":24.7682,"timestamp":1789156800000,"preClose":24.7,"halted":0,"volume":23894,"hourTrading":{"tag":"盘后","latestPrice":24.82,"preClose":24.7682,"latestTime":"19:30 EDT","volume":41,"amount":1012.1888,"timestamp":1789169404986,"change":0.0518,"changeRate":0.002091,"amplitude":0},"delay":0,"changeRate":0.002761133603238904,"floatShares":2244976,"shares":2244976,"eps":0,"marketStatus":"Market Closed","change":0.0682,"latestTime":"09-11 16:00:00 EDT","open":25.01,"high":25.065,"low":24.73,"amount":594144.14202,"amplitude":0.013563,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":24.7,"sharesOutstanding":1184976,"nav":24.85,"aum":57650992.8,"dividendRate":0.06883,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":24.9423,"preClose":24.7,"latestTime":"09:15 EDT","volume":15,"amount":370.79841,"timestamp":1789132538199,"change":0.2423,"changeRate":0.00981,"amplitude":0.022603},"postHourTrading":{"tag":"盘后","latestPrice":24.82,"preClose":24.7682,"latestTime":"19:30 EDT","volume":41,"amount":1012.1888,"timestamp":1789169404986,"change":0.0518,"changeRate":0.002091,"amplitude":0},"volumeRatio":0.6079836362295901,"impliedVol":0.5428,"impliedVolPercentile":0.9004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","floatShares":2244976,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6079836362295901,"shares":2244976,"dividePrice":1.7048,"high":25.065,"amplitude":0.013563,"preClose":24.7,"low":24.73,"week52Low":15.6348,"pbRate":"--","week52High":27.0175,"institutionHeld":0,"latestPrice":24.7682,"eps":0,"divideRate":0.06883,"volume":23894,"delay":0,"ttmEps":0,"open":25.01,"prevYearClose":17.17,"prevWeekClose":24.86,"prevMonthClose":24.62,"prevQuarterClose":24.05,"fiveDayClose":24.59,"twentyDayClose":25.2456,"sixtyDayClose":19.5761},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSIL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PSIL","amount":1.68387,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2025-09-22","symbol":"PSIL","amount":0.02007,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-29"},{"date":"2025-06-23","symbol":"PSIL","amount":0.01191,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-21","symbol":"PSIL","amount":0.16343,"announcedDate":"2025-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSIL","amount":0.05477,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSIL\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-26","recordDate":"2022-09-27","paymentDate":"2022-09-30","value":0.05421,"currency":"USD"},{"executeDate":"2023-09-25","recordDate":"2023-09-26","paymentDate":"2023-09-29","value":0.00336,"currency":"USD"},{"executeDate":"2024-09-23","recordDate":"2024-09-23","paymentDate":"2024-09-30","value":0.1087,"currency":"USD"},{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.05477,"currency":"USD"},{"executeDate":"2025-03-21","recordDate":"2025-03-21","paymentDate":"2025-03-28","value":0.16343,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSIL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSIL\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654436048","title":"Compass Pathways PLC Expected to Post a Loss of 40 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2654436048","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654436048?lang=en_us&edition=fundamental","pubTime":"2026-07-27 21:03","pubTimestamp":1785157388,"startTime":"0","endTime":"0","summary":"Compass Pathways PLC <CMPS.OQ> expected to post a loss of40cents a share - Earnings PreviewCompass Pathways PLCCMPS.OQCMPS.Ois expected to  show no change in quarterly revenue when it reports  results","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nL8N43T154:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PSIL","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654485310","title":"Compass Pathways Initiated at Equal-Weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2654485310","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654485310?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:52","pubTimestamp":1785156720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CMPS/analyst-ratings(END) Dow Jones NewswiresJuly 27, 2026 08:52 ET","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310799852.SGD","FTXO","LU0072461881.USD","LU2361045086.USD","BK4139","IE000M9KFDE8.USD","LU0971096721.USD","LU1668664300.SGD","LU1506573853.SGD","LU1894683348.USD","PGF","TFNS","LU0052756011.USD","IE0002270589.USD","LU0648001328.SGD","LU0208291251.USD","LU2361044865.SGD","LU1201861249.SGD","LU0256863811.USD","LU0130517989.USD","LU0251131958.USD","IYF","LU0029864427.USD","LU0417517546.SGD","KBWB","LU1069347547.HKD","LU0314106906.USD","LU0868494708.USD","LU0683600562.USD","LU2361044949.HKD","LU0310800379.SGD","LU0708994859.HKD","LU0980610538.SGD","LU1791807156.HKD","PSIL","IE00B19Z3581.USD","BK4585","LU0070302665.USD","BK4501","LU1280957306.USD","LU0128525689.USD","CMPS","LU0477156953.USD","BK4582","LU0048573561.USD","LU0128525929.USD","LU0289960550.SGD","LU0251142724.SGD","LU1267930490.SGD","LU1267930227.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654017757","title":"Wells Fargo Initiates COMPASS Pathways at Equalweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2654017757","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654017757?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:12","pubTimestamp":1785154373,"startTime":"0","endTime":"0","summary":"COMPASS Pathways (CMPS) has an average rating of buy and mean price target of $22.86, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ba","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4559","LU0128525929.USD","LU1814569148.SGD","LU0314106906.USD","LU0052756011.USD","LU1894683264.USD","KBWB","LU1069347547.HKD","IE000M9KFDE8.USD","IYF","PSIL","BK4585","LU1074936037.SGD","LU2361044949.HKD","LU0868494617.USD","LU1791807156.HKD","LU0648001328.SGD","CMPS","LU0683600562.USD","LU1506573853.SGD","WFC","LU0310800965.SGD","LU0048573561.USD","LU0320765489.SGD","LU2361044865.SGD","LU1267930573.SGD","LU2236285917.USD","PGF","LU0251142724.SGD","LU0070302665.USD","LU1201861249.SGD","LU1280957306.USD","LU0708994859.HKD","LU0417517546.SGD","LU0211327993.USD","LU0267386448.USD","LU0211328371.USD","BK4139","BK4501","LU0162691827.USD","BK4588","LU2361045086.USD","TFNS","LU0072461881.USD","LU2461242641.AUD","LU0106831901.USD","LU0787776722.HKD","BK4207","LU0130102774.USD","FTXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654016997","title":"Compass Pathways initiated with an Equal Weight at Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2654016997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654016997?lang=en_us&edition=fundamental","pubTime":"2026-07-27 17:25","pubTimestamp":1785144306,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Benjamin Burnett initiated coverage of Compass Pathways (CMPS) with an Equal Weight rating and $13 price target While the two p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/compass-pathways-initiated-with-an-equal-weight-at-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/compass-pathways-initiated-with-an-equal-weight-at-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IYF","LU1069347547.HKD","LU1074936037.SGD","IE0002270589.USD","LU1267930490.SGD","LU0310799852.SGD","LU0072461881.USD","LU0683600562.USD","LU0742534661.SGD","LU0640476718.USD","BK4559","PGF","FTXO","LU1791807156.HKD","LU2236285917.USD","LU0211328371.USD","TFNS","LU0310800379.SGD","LU0175139822.USD","LU0942090050.USD","LU0971096721.USD","LU1267930573.SGD","PSIL","LU1894683348.USD","LU0029864427.USD","LU0320765489.SGD","LU1668664300.SGD","LU2361044865.SGD","CMPS","LU2461242641.AUD","LU2361045086.USD","LU0130102774.USD","BK4585","LU1363072403.SGD","LU0314106906.USD","BK4139","LU0417517546.SGD","LU1201861249.SGD","BK4582","LU1035773651.USD","LU0251142724.SGD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU0048573561.USD","LU1267930227.SGD","BK4207","KBWB","BK4501","LU1894683264.USD","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654054554","title":"Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Celldex (CLDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654054554","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654054554?lang=en_us&edition=fundamental","pubTime":"2026-07-25 22:50","pubTimestamp":1784991019,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Celldex (CLDX) with bullish sent...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-celldex-cldx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-celldex-cldx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLDX","BK4581","ALKS","IBRN","LABU","LU0128526141.USD","HCSG","PSIL","BK4137","XLV","BK4585","PSCH","BK4139","LU0029874061.USD","XBI","BK4588","FBT","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654036222","title":"Bristol-Myers Squibb Advances New Lung Cancer Combo Into Phase 2: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2654036222","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654036222?lang=en_us&edition=fundamental","pubTime":"2026-07-25 00:34","pubTimestamp":1784910898,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Bristol-Myers Squibb is running a Phase 2 trial to test a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bristol-myers-squibb-advances-new-lung-cancer-combo-into-phase-2-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bristol-myers-squibb-advances-new-lung-cancer-combo-into-phase-2-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1983299246.USD","LU0267386448.USD","LU0321505868.SGD","LU1868836757.USD","LU0306806265.USD","BK4007","ISBC","LU0985481810.HKD","LU1291159041.SGD","BK4532","LU1074936037.SGD","BK4534","LU1670711040.USD","IE00B2B36J28.USD","LU2125154778.USD","LU1670710661.SGD","LU1670710588.SGD","IE00BFTCPJ56.SGD","LU0061475181.USD","LU0114720955.EUR","BK4585","IE00BFXG1179.USD","LU1868836591.USD","LU1093756168.USD","LU0456855351.SGD","LU1093756325.SGD","BK4581","LU0432979614.USD","PSIL","LU1868837136.USD","LU0306807586.USD","LU1868836914.USD","BBC","LU2125154935.USD","LU0237698245.USD","BK4211","LU0882574055.USD","BK4588","IHE","LU1261432733.SGD","LU1323610961.USD","LU2242646821.SGD","BMY","LU0321505439.SGD","IE00BSNM7G36.USD","LU0225284248.USD","IE00BJJMRZ35.SGD","LU0225771236.USD","FTXH","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654362520","title":"Takeda’s Elritercept Trial Targets Anemia in Myelofibrosis, Raising Long-Term Upside for TAK","url":"https://stock-news.laohu8.com/highlight/detail?id=2654362520","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654362520?lang=en_us&edition=fundamental","pubTime":"2026-07-25 00:34","pubTimestamp":1784910878,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda is running a Phase 3 trial to test elritercept (TA...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-elritercept-trial-targets-anemia-in-myelofibrosis-raising-long-term-upside-for-tak?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-elritercept-trial-targets-anemia-in-myelofibrosis-raising-long-term-upside-for-tak?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BK4007","TAK","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654036255","title":"Jazz Pharmaceuticals Advances Phase 3 Cannabidiol Trial in Severe Childhood Epilepsy","url":"https://stock-news.laohu8.com/highlight/detail?id=2654036255","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654036255?lang=en_us&edition=fundamental","pubTime":"2026-07-25 00:33","pubTimestamp":1784910829,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals ($JAZZ) announced an update on their ongoing clinical study. Jazz Pharmaceuticals is preparing a Phase 3 trial to test a new o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jazz-pharmaceuticals-advances-phase-3-cannabidiol-trial-in-severe-childhood-epilepsy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jazz-pharmaceuticals-advances-phase-3-cannabidiol-trial-in-severe-childhood-epilepsy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653204084","title":"Organon to present results from analysis of Phase 3 trials of VTAMA cream","url":"https://stock-news.laohu8.com/highlight/detail?id=2653204084","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653204084?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:11","pubTimestamp":1784895078,"startTime":"0","endTime":"0","summary":"Organon (OGN) will present results from a post hoc analysis of pooled data from the Phase 3 pivotal trials, ADORING 1 and ADORING 2, evaluating the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/organon-to-present-results-from-analysis-of-phase-3-trials-of-vtama-cream-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/organon-to-present-results-from-analysis-of-phase-3-trials-of-vtama-cream-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065170008.USD","OGN","LU2065169927.USD","PSIL","BK4585","FXH","BK4588","BK4559","BBC","LU2065171311.SGD","BK4007","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653702156","title":"Radiopharm outlines capital raising plans and risk warnings for oncology radiopharma platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2653702156","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653702156?lang=en_us&edition=fundamental","pubTime":"2026-07-24 15:38","pubTimestamp":1784878698,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Radiopharm Theranostics Limited ( ($AU:RAD) ). Radiopharm Theranostics has released a capital raising presentat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/radiopharm-outlines-capital-raising-plans-and-risk-warnings-for-oncology-radiopharma-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/radiopharm-outlines-capital-raising-plans-and-risk-warnings-for-oncology-radiopharma-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653063997","title":"Lightning Minerals shareholders back all capital raising resolutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2653063997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653063997?lang=en_us&edition=fundamental","pubTime":"2026-07-24 13:03","pubTimestamp":1784869393,"startTime":"0","endTime":"0","summary":"An announcement from Lightning Minerals Ltd. ( ($AU:L1M) ) is now available. Lightning Minerals Ltd shareholders approved all resolutions put forwa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lightning-minerals-shareholders-back-all-capital-raising-resolutions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lightning-minerals-shareholders-back-all-capital-raising-resolutions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","MTX","BK4109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653708145","title":"Kringle Pharma Launches Additional Phase 3 Trial of Oremepermin Alfa in Acute Spinal Cord Injury","url":"https://stock-news.laohu8.com/highlight/detail?id=2653708145","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653708145?lang=en_us&edition=fundamental","pubTime":"2026-07-24 10:52","pubTimestamp":1784861536,"startTime":"0","endTime":"0","summary":"Kringle Pharma, Inc. ( ($JP:4884) ) has shared an announcement. Kringle Pharma has launched an additional Phase 3 trial in Japan to evaluate oremep...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kringle-pharma-launches-additional-phase-3-trial-of-oremepermin-alfa-in-acute-spinal-cord-injury?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kringle-pharma-launches-additional-phase-3-trial-of-oremepermin-alfa-in-acute-spinal-cord-injury?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4135","JP","BBC","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653772545","title":"X2M Connect Plans Major Share and Option Issue on ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2653772545","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653772545?lang=en_us&edition=fundamental","pubTime":"2026-07-24 08:08","pubTimestamp":1784851687,"startTime":"0","endTime":"0","summary":"The latest update is out from X2M Connect Limited ( ($AU:X2M) ). X2M Connect Limited has notified the ASX of a proposed capital raising involving t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/x2m-connect-plans-major-share-and-option-issue-on-asx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/x2m-connect-plans-major-share-and-option-issue-on-asx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653399774","title":"Dalaroo board backs A$1.75m raising to drive gold and rare earths push","url":"https://stock-news.laohu8.com/highlight/detail?id=2653399774","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653399774?lang=en_us&edition=fundamental","pubTime":"2026-07-24 06:44","pubTimestamp":1784846651,"startTime":"0","endTime":"0","summary":"Dalaroo Metals Ltd. ( ($AU:DAL) ) has shared an announcement. Dalaroo Metals has completed the second tranche of a capital raising, securing about ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dalaroo-board-backs-a1-75m-raising-to-drive-gold-and-rare-earths-push?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dalaroo-board-backs-a1-75m-raising-to-drive-gold-and-rare-earths-push?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLTR","FGDL","PICK","GDXJ","DGP","GLDM","PHYS","SGOL","UGL","GDXY","AAAU","XME","OUNZ","YGLD","GDX","BEGS","DBC","BAR","DZZ","RING","UYM","DULL","PSIL","GOLY","GLD","IAU","JNUG","USG","1OZmain","DUST","REMX","FXZ","GOAU","IAUI","JETS","GDXD","MVPS","CRIT","BTGD","PPI","SHNY","DGZ","SGDM","IAUM","GBUG","JDST","GDXU","DAL","GLL","CEF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653939797","title":"Verastem doses first patient in TARGET-D 202 Phase 2 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2653939797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653939797?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:06","pubTimestamp":1784750793,"startTime":"0","endTime":"0","summary":"Verastem (VSTM) Oncology announced that the first patient has been dosed in the TARGET-D 202 Phase 2 registration-directed trial evaluating VS-7375...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/verastem-doses-first-patient-in-target-d-202-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/verastem-doses-first-patient-in-target-d-202-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BBC","PSIL","VSTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653623367","title":"Arrowhead Pharmaceuticals (ARWR) Stock Soars on Strong Phase 3 Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2653623367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653623367?lang=en_us&edition=fundamental","pubTime":"2026-07-23 01:01","pubTimestamp":1784739666,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals stock saw major gains after the company announced new results from a Phase 3 trial.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/arrowhead-pharmaceuticals-arwr-stock-soars-on-strong-phase-3-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/arrowhead-pharmaceuticals-arwr-stock-soars-on-strong-phase-3-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","PSIL","BK4139","BK4588","BBC","ARWR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653754039","title":"NRX Pharmaceuticals - on July 21, Nrxd Selected by Darpa for Negotiation of Potential Sparc-tms Clinical Trial Award - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2653754039","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653754039?lang=en_us&edition=fundamental","pubTime":"2026-07-22 19:08","pubTimestamp":1784718511,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nFWN43O0MI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653644758","title":"Right Resources secures ASX waiver to advance shareholder-backed capital raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2653644758","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653644758?lang=en_us&edition=fundamental","pubTime":"2026-07-22 16:12","pubTimestamp":1784707936,"startTime":"0","endTime":"0","summary":"Right Resources Limited ( ($AU:RRE) ) has provided an update. Right Resources Limited has outlined details of its proposed capital raising, combini...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/right-resources-secures-asx-waiver-to-advance-shareholder-backed-capital-raising?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/right-resources-secures-asx-waiver-to-advance-shareholder-backed-capital-raising?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653778286","title":"Codeifai Plans Major ASX Placement of Shares and Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2653778286","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653778286?lang=en_us&edition=fundamental","pubTime":"2026-07-22 08:37","pubTimestamp":1784680633,"startTime":"0","endTime":"0","summary":"YPB Group Ltd. ( ($AU:CDE) ) has shared an update. Codeifai Limited has announced a proposed capital raising involving the issue of new securities ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/codeifai-plans-major-asx-placement-of-shares-and-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/codeifai-plans-major-asx-placement-of-shares-and-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653781076","title":"Aguia Resources Raises $3 Million to Advance Phosphate and Gold Projects","url":"https://stock-news.laohu8.com/highlight/detail?id=2653781076","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653781076?lang=en_us&edition=fundamental","pubTime":"2026-07-22 08:13","pubTimestamp":1784679189,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Aguia Resources Limited ( ($AU:AGR) ). Aguia Resources Limited has completed a $3 million capital raising via a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aguia-resources-raises-3-million-to-advance-phosphate-and-gold-projects?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aguia-resources-raises-3-million-to-advance-phosphate-and-gold-projects?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}